Ribéreau-Gayon G - Search Results

1

Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.

Ribéreau-Gayon G, Jung ML, Di Scala D, Beck JP. Ribéreau-Gayon G, et al. Oncology. 1986;43 Suppl 1:35-41. doi: 10.1159/000226418. Oncology. 1986. PMID: 3808575

2

Characterization of cytotoxic proteins from mistletoe (Viscum album L.).

Jung ML, Baudino S, Ribéreau-Gayon G, Beck JP. Jung ML, et al. Among authors: ribereau gayon g. Cancer Lett. 1990 May 30;51(2):103-8. doi: 10.1016/0304-3835(90)90044-x. Cancer Lett. 1990. PMID: 2344587

3

Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells.

Ribéreau-Gayon G, Jung ML, Baudino S, Sallé G, Beck JP. Ribéreau-Gayon G, et al. Experientia. 1986 Jun 15;42(6):594-9. doi: 10.1007/BF01955552. Experientia. 1986. PMID: 3013672

4

Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.

Ribéreau-Gayon G, Jung ML, Frantz M, Anton R. Ribéreau-Gayon G, et al. Anticancer Drugs. 1997 Apr;8 Suppl 1:S3-8. doi: 10.1097/00001813-199704001-00002. Anticancer Drugs. 1997. PMID: 9179359 Review.

5

Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: homology with ricin-like plant toxins and single-chain ribosome-inhibiting proteins.

Dietrich JB, Ribéreau-Gayon G, Jung ML, Franz H, Beck JP, Anton R. Dietrich JB, et al. Among authors: ribereau gayon g. Anticancer Drugs. 1992 Oct;3(5):507-11. doi: 10.1097/00001813-199210000-00010. Anticancer Drugs. 1992. PMID: 1450445

6

Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes.

Ribéreau-Gayon G, Dumont S, Muller C, Jung ML, Poindron P, Anton R. Ribéreau-Gayon G, et al. Cancer Lett. 1996 Dec 3;109(1-2):33-8. doi: 10.1016/s0304-3835(96)04401-1. Cancer Lett. 1996. PMID: 9020900

7

Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins.

Frantz M, Jung ML, Ribereau-Gayon G, Anton R. Frantz M, et al. Among authors: ribereau gayon g. Arzneimittelforschung. 2000 May;50(5):471-8. doi: 10.1055/s-0031-1300232. Arzneimittelforschung. 2000. PMID: 10858875

8

Are lectins of Viscum album interesting tools in lung diseases? A review of recent results.

Luther P, Uhlenbruck G, Reutgen H, Samtleben R, Sehrt I, Ribereau-Gayon G. Luther P, et al. Among authors: ribereau gayon g. Z Erkr Atmungsorgane. 1986;166(3):247-56. Z Erkr Atmungsorgane. 1986. PMID: 2428175

9

Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor.

Ribéreau-Gayon G, Palfreyman MG, Zraïka M, Wagner J, Jung MJ. Ribéreau-Gayon G, et al. Biochem Pharmacol. 1980 Sep 15;29(18):2465-9. doi: 10.1016/0006-2952(80)90350-0. Biochem Pharmacol. 1980. PMID: 7426053 No abstract available.

10

Monamine-depleting properties of a new and very potent enzyme-activated irreversible inhibitor of aromatic aminoacid decarboxylase: alpha-monofluoromethyldopa [proceedings].

Jung MJ, Palfreyman MG, Ribereau-Gayon G, Wagner J, Zraïka M. Jung MJ, et al. Among authors: ribereau gayon g. Br J Pharmacol. 1979 Nov;67(3):460P. Br J Pharmacol. 1979. PMID: 497577 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters